Board Meeting7 Oct 2026, 08:40 pm
Sun Pharma Board to Consider INR 15,000 Cr NCD Issuance
AI Summary
Sun Pharmaceutical Industries Ltd has announced that its Board of Directors will convene on October 12, 2026, to consider and approve the issuance of listed, rated, unsecured, redeemable non-convertible debentures (NCDs). The issuance will be in one or more tranches, on a private placement basis, for an aggregate amount not exceeding INR 15,000 Crore. The meeting will also address matters incidental and connected to this potential fundraising.
Key Highlights
- Board meeting scheduled for October 12, 2026.
- To consider issuance of NCDs up to INR 15,000 Crore.
- Issuance will be on a private placement basis.
- NCDs will be listed, rated, unsecured, and redeemable.
Price Impact
More from SUNPHARMA